News and Announcements
Altech Signs Off Take Agreement for 100% of HPA Production
- Published April 27, 2016 12:17PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
27th April 2016, ASX Announcement
Highlights:
- Altech signs off take sales arrangement with Mitsubishi for first ten years of HPA operations
- Secures sales for 100% of Altech’s proposed 4,000tpa HPA production
- Exclusive global distributor with well established global customer base
- Mitsubishi Corporation is Japan’s largest global trading company
Altech Chemicals Limited (Altech the Company) (ASX:ATC) is pleased to announce that it has executed a 10 year off take sales arrangement (Agreement) with Mitsubishi Corporation’s Australian subsidiary, Mitsubishi Australia Ltd (Mitsubishi) for 100% of the high purity alumina (HPA) production from the Company’s proposed Malaysian HPA plant.
To view the full article please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
